JAZZ News and Press, Jazz Pharmaceuticals plc From 06/29/21

If you have $5,000 available to invest in stocks, there are some great options out there for you. The three stocks I have listed below are underrated investments and are trading at low earnings multiples -- and 2021 could be a great year for all three of them. You don't want to make the mis...

Jazz Pharmaceuticals (JAZZ) announces that the FDA has recognized seven years of Orphan Drug Exclusivity for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of cataplexy or excessive daytime sleepiness ((EDS)) in patients 7 years of age and older wit...

Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution PR Newswire U.S. Food and Drug Administration published its summary of clinical superiority findings for Xywav for the treatment ...

Real Brands Inc (OTCMKTS:RLBD) is almost a quarter owned by Turning Point Brands, Inc. (NYSE:TPB), which is a third owned by a multi-billion dollar hedge fund with a vested interest in helping TPB, and its major interests and partners, secure necessary financing on strong investor-friendly te...

Illumina (ILMN), Jazz Pharmaceuticals (JAZZ), and Amgen (AMGN) are 3 of the top biotech stocks. The sector has been an underperformer over the last few years but could start outperforming given the aging population, low valuation, and growth potential. Though the iShares Nasdaq Biotech...

Zhanna Hapanovich/iStock via Getty Images Jazz Pharmaceuticals (JAZZ) estimates ~18.1% of additional revenue in 2021 as a result of the acquisition of GW Pharmaceuticals (GWPH), the updated financial guidance issued by the company for this year indicates. Including the projected results ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of  GW Pharmaceuticals, which was bought on May 5, 2021. The May 4, 2021 guidance for revenue was in the range of $2.5 – $2.7 billion. That has been increa...

Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc 2021 Total Revenue Guidance Increased to a Range of $3.02 Billion to $3.18 Billion Acquisition of GW Expected to Drive Accelerated Revenue Growth and Diversification ...

2 Marijuana Stock To Add To Your Watchlist This Month Now that marijuana stocks have met the half point of June trading is still a bit volatile. Yet for the better half of the last 6 weeks, cannabis stocks have started to show a bit more consistency in trading momentum. This has hel...

Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer Community Nothing Small About It (www.nothingsmallaboutit.com) is a support and edu...